Skip to main content
PMC home page
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2017 Jun 8;8:1033. doi: 10.3389/fmicb.2017.01033

Propionibacterium freudenreichii Surface Protein SlpB Is Involved in Adhesion to Intestinal HT-29 Cells

Fillipe L R do Carmo 1,2, Houem Rabah 2,3, Song Huang 2,4, Floriane Gaucher 2, Martine Deplanche 2, Stéphanie Dutertre 5, Julien Jardin 2, Yves Le Loir 2, Vasco Azevedo 1,†, Gwénaël Jan 2,*,†
PMCID: PMC5462946  PMID: 28642747

Abstract

Propionibacterium freudenreichii is a beneficial bacterium traditionally used as a cheese ripening starter and more recently for its probiotic abilities based on the release of beneficial metabolites. In addition to these metabolites (short-chain fatty acids, vitamins, and bifidogenic factor), P. freudenreichii revealed an immunomodulatory effect confirmed in vivo by the ability to protect mice from induced acute colitis. This effect is, however, highly strain-dependent. Local action of metabolites and of immunomodulatory molecules is favored by the ability of probiotics to adhere to the host cells. This property depends on key surface compounds, still poorly characterized in propionibacteria. In the present study, we showed different adhesion rates to cultured human intestinal cells, among strains of P. freudenreichii. The most adhesive one was P. freudenreichii CIRM-BIA 129, which is known to expose surface-layer proteins. We evidenced here the involvement of these proteins in adhesion to cultured human colon cells. We then aimed at deciphering the mechanisms involved in adhesion. Adhesion was inhibited by antibodies raised against SlpB, one of the surface-layer proteins in P. freudenreichii CIRM-BIA 129. Inactivation of the corresponding gene suppressed adhesion, further evidencing the key role of slpB product in cell adhesion. This work confirms the various functions fulfilled by surface-layer proteins, including probiotic/host interactions. It opens new perspectives for the understanding of probiotic determinants in propionibacteria, and for the selection of the most efficient strains within the P. freudenreichii species.

Keywords: adhesion, immunomodulation, surface proteins, probiotic, SlpB

Introduction

Propionibacterium freudenreichii is a GRAS (Generally Recognized As Safe) actinobacterium consumed in high amounts in fermented dairy products. It is a beneficial bacterium used in the food industry for the production of vitamins, for cheese ripening, and for its probiotic properties (Cousin et al., 2010). Probiotics are defined as “living microorganisms which when administered in adequate amounts confer a health benefit on the host” (Food and Agriculture Organization of the United Nations and World Health Organization, 2002). P. freudenreichii indeed revealed probiotic traits including modulation of intestinal inflammation (Mitsuyama et al., 2007; Foligné et al., 2010, 2013), as well as properties linked to the production of beneficial metabolites such as short-chain fatty acids (Jan et al., 2002; Lan et al., 2007; Cousin et al., 2012b), vitamins and the bifidogenic compound 1,4-dihydroxy-2-naphthoic acid (DHNA) (Bouglé et al., 1999; Kaneko, 1999; Hojo et al., 2002; Ouwehand et al., 2002; Seki et al., 2004; Mitsuyama et al., 2007).

Microorganisms that live in or transit through the digestive tract of humans may establish a symbiotic relationship with the host, thus promoting intestinal homeostasis (de Souza and Fiocchi, 2016). Consumption of P. freudenreichii selected strains can enhance human complex intestinal microbiota through the increase of other beneficial bacteria populations, such as bifidobacteria (Bouglé et al., 1999; Kaneko, 1999; Hojo et al., 2002; Ouwehand et al., 2002; Seki et al., 2004; Mitsuyama et al., 2007). In contrast, out of normal physiological conditions, the digestive microbiota may be involved in a variety of immune and inflammatory disorders (Vitetta et al., 2014). One example is inflammatory bowel diseases (IBD), chronic inflammatory disorders that severely affect the digestive tract and may lead, in the long term, to the irreversible deterioration of their structure and function (Belkaid and Hand, 2014; Vitetta et al., 2015). Cheese containing P. freudenreichii, in conjunction with Lactobacillus delbrueckii (Plé et al., 2016) or as a single strain (Plé et al., 2015), was recently shown to exert immunomodulatory effects, to protect mice against TNBS-induced colitis, to alleviate the severity of symptoms and to modulate local and systemic inflammation markers. Such cheese is currently tested in a pilot clinical trial (ClinicalTrials.gov, 2017). Interestingly, removal of propionibacteria surface-layer (S-layer) proteins, which are non-covalently anchored to the cell surface via an S-layer homology (SLH) domain, suppressed the induction of anti-inflammatory cytokines (Foligné et al., 2010). By contrast, some P. freudenreichii strains that possess an extracellular polysaccharide capsule fail to immunomodulate, while mutagenetic suppression of this capsule confers immunomodulatory activity (Deutsch et al., 2012).

Surface proteins of P. freudenreichii ITG P20 [Centre International de Ressources Microbiennes-Bactéries d’Intérêt Alimentaire (CIRM-BIA) 129], which is used as a cheese ripening starter (Richoux et al., 1998; Thierry et al., 2004), were investigated by a combination of proteomic methods previously developed for bacteria and eukaryotic cells (Lortal et al., 1993; Mayrhofer et al., 2006; Rodríguez-Ortega et al., 2006; Berlec et al., 2011; Bøhle et al., 2011; Bensi et al., 2012; Ythier et al., 2012; Michaux et al., 2013). This investigation demonstrated the involvement of certain S-layer proteins in immunomodulation (Bryson et al., 2006; Le Maréchal et al., 2015). Surface proteins, susceptible to enzymatic shaving and to guanidine extraction, were shown to be involved in the ability of P. freudenreichii to modulate the release of cytokines by human immune cells (Le Maréchal et al., 2015). However, the respective role of the different bacterial S-layer proteins was not fully elucidate. Immunomodulation is favored by the ability of specific strains to adhere to the host cells and mucus (Tuomola et al., 1999; Ouwehand et al., 2000; Huang and Adams, 2003; Thiel et al., 2004; Le Maréchal et al., 2015). Indeed, the local action of metabolites and of immunomodulatory molecules is favored by the ability of probiotics to adhere to the host cells. Dairy propionibacteria were shown to adhere to mice intestinal epithelial cells both ex vivo and in vivo (Zarate, 2012) as well as to cultured human intestinal cell lines in vitro (Huang and Adams, 2003; Moussavi and Adams, 2010). However, the precise mechanisms are poorly characterized in P. freudenreichii. Adhesion moreover constitutes a key criterion in strain selection and is described as the initial step for colonization of the host (Havenaar et al., 1992, havenar; Riedel et al., 2006; Preising et al., 2010), depending on crucial surface compounds, including surface proteins (Lebeer et al., 2010).

The identification of adhesion mechanisms and molecules is a fundamental step in the elucidation of the bacterium/host cross-talk (van de Guchte et al., 2012). This was lacking in probiotic dairy propionibacteria. The aim of our study was thus to identify P. freudenreichii protein(s) involved in adhesion to human intestinal epithelial cells.

Materials and Methods

Bacterial Strains and Culture Conditions

The P. freudenreichii wild-type (WT) strains, genetically modified strain and plasmids used in this study are listed in Table 1. All strains in this study were obtained from the collection of the CIRM-BIA (STLO, INRA Rennes, France). All P. freuderenichii WT strains were grown at 30°C in YEL broth (Malik et al., 1968) without agitation or in cow’s milk ultrafiltrate supplemented with 50 mM of sodium L-lactate (galaflowSL60, Société Arnaud, Paris, France) and 5 g/L of casein hydrolysate (Organotechnie, La Courneuve, France), sterilized by 0.2 μm filtration (Nalgene, Roskilde, Denmark) as described previously (Cousin et al., 2012a). For genetically modified strains, YEL and Milk Ultrafiltrate culture media were supplemented with chloramphenicol (10 μg ml-1). The growth of P. freudenreichii strains was monitored spectrophotometrically by measuring the optical density at 650 nm (OD650), as well as by counting colony-forming units (CFUs) in YEL medium (Malik et al., 1968) containing 1.5% agar. P. freudenreichii strains was harvested in a stationary phase (76 h, 109 CFU/mL, determined by plate counts) by centrifugation (6,000 × g, 10 min, 4°C). Escherichia coli strain DH5α was grown in Luria–Bertani medium at 37°C, and cells carrying DNA plasmid were selected by addition of ampicillin (100 μg ml-1).

Table 1.

Propionibacterium freudenreichii wild-type strains, their genetically modified derivatives and plasmids used in the study.

Strains and plasmids Relevant genotype and phenotype Source or reference
Strains P. freudenreichiia
CB 118 Wild-type; SlpA, SlpB, SlpE, and InlA proteins detected in guanidine extractb CIRM-BIA
CB 121 Wild-type; InlA and LspA proteins detected in guanidine extract CIRM-BIA
CB 129 Wild-type; SlpA, SlpB, SlpE, InlA, and LspA proteins detected in guanidine extract CIRM-BIA
CB 134 Wild-type; SlpA, SlpE, InlA, and LspA proteins detected in guanidine extract CIRM-BIA
CB 136 Wild-type; SlpA, SlpB, InlA, and LspA proteins detected in guanidine extract CIRM-BIA
CB 508 Wild-type; SlpA, SlpB, SlpE, InlA, and LspA proteins detected in guanidine extract CIRM-BIA
CB 527 Wild-type; Absence of surface layer proteins in guanidine extract CIRM-BIA
CB 129ΔslpB Cmr; CIRM-BIA 129 with chromosomal insertion of pUC:ΔslpB:CmR in the slpB sequence; SlpB protein absent in guanidine extract This Study
Plasmids
pUC:slpB pUC18; Amp; harboring slpB partial gene sequence for inactivation This Study
pUC:ΔslpB:CmR pUC18 carrying a chloramphenicol resistance gene and harboring slpB partial gene sequence This Study
Open in a new tab

aCB, CIRM-BIA, Centre International de Ressources Microbiennes–Bactéries d’Intérêt Alimentaire, INRA, UMR 1253, Science et Technologie du Lait et de l’Oeuf, Rennes, France. bGuanidine Hydrochloride treatment used to extract surface layer associated proteins non-covalently bound to the surface is described in “Materials and Methods.”

Enzymatic Shaving of Surface Proteins

One hundred microliter of propionibacteria stationary phase culture (see above) were harvested by centrifugation (6,000 × g, 10 min, 4°C) and washed in an equal volume of PBS [pH 8.5] containing 5 mM DTT before resuspension in 1/10 volume of the same buffer. Sequencing grade modified trypsin (V5111, Promega, Madison, WI, United States) was dissolved in the same buffer (qsp 0.2 g/L) and added to the bacterial suspension. “Shaving” was performed for 1 h at 37°C in a 0.5 mL reaction volume containing 5 × 109 bacteria and 4 μg of trypsin, with gentle agitation (180 rpm). Bacteria were removed by centrifugation (8,000 × g, 10 min, 20°C) and subjected to three washes in PBS prior to adhesion assay.

Cell Line and Culture Conditions

The human colon adenocarcinoma cell line HT-29 was obtained from ATCC (American Type Culture Collection, Rockville, MD, United States). These cells was cultured under conditions of 37°C, 5% CO2, and 90% relative humidity in DMEM High Glucose with L-Glutamine with Sodium Pyruvate (PAN, Dominique Dutscher, Brumath, France) supplemented with 10% heat-inactivated fetal calf serum (FCS) (PAN, Dominique Dutscher, Brumath, France) and antibiotics or not (for adhesion assays).

Electroporation and Inactivation of the slpB Gene in P. freudenrenichii CIRM-BIA 129 by Suicide Vector

Inactivation of P. freudenreichii gene was adapted from Deutsch et al. (2012) with some modifications. For insertional inactivation of a slpB gene, a 520-bp DNA fragment homologous to nucleotides 30–550 of the 5′ region of the slpB coding region in P. freudenreichii CIRM-BIA 129 genome was synthesized by Genscript Inc.1 with restriction sites XbaI-slpB-5′ and BamHI-slpB-3′ resulting in pUC:ΔslpB plasmid. The pUC:ΔslpB plasmidic DNA was digested with XbaI and BamHI, purified, and cloned in plasmid pUC:CmR digested by the same enzymes, which resulted in the suicide vector pUC:ΔslpB:CmR, which was confirmed by sequencing. See Supplementary Figure S2.

Electrocompetent P. freudenreichii CIRM-BIA 129 cells was prepared as previously described (Deutsch et al., 2012) with slight modifications. They were cultured in YEL medium supplemented with 0.5 M sucrose and 2% glycine until the early exponential growth phase (OD = 0.1), harvested (6,000 × g, 10 min, 4°C). The pellet was washed extensively in ice-cold 0.5 M sucrose and resuspended in electroporation buffer containing 0.5 M sucrose with 10% glycerol and 1 mM potassium acetate (pH 5.5). For electroporation, a 100-μl aliquot of the electrocompetent cells was mixed with 3 μg of pUC:ΔslpB:CmR plasmid DNA in a cooled electroporation cuvette. The electroporation of P. freudenreichii CIRM-BIA 129 was performed with a Gene Pulser XcellTM (Bio-Rad Laboratories, Richmond, CA, United States) at 20 kV/cm, 200-Ω resistance, and 25-μF capacitance. Immediately after the pulse, 900 μL of YEL containing 0.5 M sucrose, 20 mM MgCl2, and 2 mM CaCl2 were added before incubation, 24 H at 30°C under microaerophilic conditions. Cells were plated, and incubated 7 days at 30°C under anaerobic conditions, on YEL medium containing 1.5% agar (YELA) supplemented with 10 μg⋅ml-1 of chloramphenicol in order to select P. freudenreichii mutants harboring inserted pUC:ΔslpB:CmR. The P. freudenreichii CIRM-BIA 129 ΔslpB (CB129ΔslpB) mutant strain was further checked by proteomics for the absence of intact SlpB surface proteins as indicated in the “Results” section. Moreover, the stability of the insertion was checked after three independent cultures in YEL and Milk Ultrafiltrate media without chloramphenicol.

In Vitro Adhesion Assays

Adhesion of P. freudenreichii (WT and mutant) to the human colon adenocarcinoma cell line HT-29 was examined by adding 108 live propionibacteria (washed twice in PBS, numerated by CFU conting, ratio 100 bacteria:1 HT-29 cell, MOI 100) to 106 cells in DMEM culture medium without antibiotics. Adhesion assay was conducted by incubation of bacteria/cell at 37°C for 60 min under conditions, 5% CO2 and 90% relative humidity. Cells were washed twice with prewarmed PBS pH 7.4, and the subsequently supernatant was removed, and 400 μL of trypsin-EDTA (Invitrogen) was added to each well, before incubation for 5 min at 37°C and to trypsin inactivation by adding 800 μL of DMEM culture medium without antibiotics. Cells were harvested (3,000 × g, 3 min) and lysed in 0.1% Triton X-100 before serial dilutions and plating on YELA. Finally, plates were incubated at 30°C for 5 days under anaerobic conditions. A rate of adhesion was calculated as follows: (bacterial count after adhesion experiment/bacterial population added on to HT29 cells). The CIRM-BIA 129 WT strain was then used as a reference in this work, with a % adhesion of 100, and used to normalize all other adhesion rates as a percentage of CIRM-BIA 129 WT adhesion. Each adhesion assay was conducted in technical and biological triplicates. To test involvement of surface proteins in adhesion, propionibacteria were subjected (or not) to enzymatic shaving (see section “Enzymatic Shaving of Surface Proteins”) before adhesion assay. To confirm this hypothesis, propionibacteria were incubated 60 min at 37°C with 50 μg of P. freudenreichii CIRM-BIA 129 guanidine-extracted S-layer associated proteins, in solution in PBS, under agitation, before adhesion. This amount (50 μg) was determined after preliminary experiments to determine amounts efficient in restoring adhesion. For specific inhibition of adhesion by antibodies directed against SlpB, propionibacteria were incubated in PBS pH 7.4 with immunoglobulins purified from rabbit anti-SlpB serum (AGRO-BIO, France) in 1:10.000 dilution, under agitation, 60 min at 37°C. Propionibacteria were washed twice with PBS pH 7.4 before adhesion assay.

The adhesion ratio of CB 129 strain alone was used as a reference to calculate the adhesion rates of different strains and treatments.

Internalization of bacteria was determined as previously described (Bouchard et al., 2013) 2-h post contact following an additional 2-h incubation step with DMEM supplemented with gentamicin (100 μg/ml) to kill extracellular bacteria. Subsequently, HT-29 cells monolayers were washed three times with PBS, treated with trypsin, centrifuged for 5 min at 800 × g, and lysed in 0.01% Triton to allow the numeration of internalized propionibacteria population only.

Bacterial Cell Adhesion Observation by Microscopy

Observation of P. freudenreichii adhesion to cultured human colon epithelial cells was as described previously for lactobacilli (Tiptiri-Kourpeti et al., 2016), with modifications for propionibacteria. Briefly, propionibacteria, cultured as described above, were washed and resuspended in PBS, prior to the addition of 20 μM CFSE (carboxyfluorescein succinimidyl ester, cell trace proliferation kit for flow cytometry ref C34554 Thermo Fisher Scientific, Waltman, MA, United States), freshly prepared as a 1,000× solution in DMSO and kept in the dark. Incorporation of CFSE was allowed for 30 min at 30°C in the dark, prior to washing and resuspension of propionibacteria in YEL medium, 30°C. Hydrolysis of CFSE by intracellular esterase activity was allowed 30 min at 30°C in the dark to generate intracellular fluorescence. Fluorescence was checked on an epifluorescence microscope (BX-51, Olympus, equipped with a U-MWB2 fluorescence filter cube). HT-29 cells were cultured in Lab-Tek chamber slide (Thermo Fisher Scientific) and labeled bacteria were added to a 1/100 ratio (1 × 106 cells, 1 × 108 bacteria, in 1 mL of DMEM) before incubation, 1 h, 37°C. After two washes with PBS, the plasma membrane of cells was then labeled with the exogenous head-labeled phospholipid fluorescent probe N-(Lissamine rhodamine B sulfonyl) dioleoyl phosphatidylethanolamine (Rh-DOPE, Avanti Polar Lipids Inc., Birmingham, England) used at a concentration of 1 μg/mL in DMEM, for 10 min. Cell layer was then washed twice with PBS and slides mounted in DAPI (4,6-diamidino-2-phenylindole)-containing mounting medium (Vectashield mounting medium for fluorescence Vector ref H-1200). Cells were observed using a confocal Leica SP8 and a 63/1.4 oilHC PL APO CS objective. Images were acquired using LAS-AF (Leica, Wetzlar, Germany) software.

For scanning electron microscopy, HT-29 cells were cultured in Corning® Transwell® polycarbonate membrane cell culture inserts on polycarbonate 0.4 μm pore size filtration membrane. Adhesion was conducted as described above. Membranes were then removed, washed in PBS, fixed 48 h by 2% (wt/vol) glutaraldehyde in 0.1 M sodium cacodylate buffer [pH 6.8] and rinsed in the same buffer. Samples were dehydrated with ethanol (10, 25, 50, 75, 95, and finally 100%), critical-point dried by the CO2 method and coated with gold. Cells were examined and photographed with a Philips XL 20 scanning electron microscope operating at 10 kV.

Bacterial Cell Adhesion Determination by Cytometric Analysis

Determination of P. freudenreichii adhesion to cultured human colon epithelial cells was performed as described previously for lactobacilli (Tiptiri-Kourpeti et al., 2016). Cells were cultured in DMEM as described above to confluence. CFSE-labeled bacteria were added as described above before a 1-h incubation at 37°C. Cells were trypsinized and analyzed by fluorescence cytometry using an excitation wavelength of 488 and emission at 585 nm (Accuri C6 Becton Dickinson, Le Pont-de-Claix, France). Data were collected from 50,000 cells and analysis was performed with CFlow software.

Guanidine Extraction of Surface Layer Associated Proteins Non-covalently Bound to the Cell Wall

Propionibacteria cultures in stationary phase (76-h) were collected by centrifugation (8,000 × g, 10 min, 4°C) for extraction of S-layer proteins by Guanidine Hydrochloride (GuaHCl) (Le Maréchal et al., 2015). The bacterial pellet was washed two times with an equal volume of PBS buffer pH 7.4. This pellet was resuspended in 5 M GuaHCl to a final OD650 of 20 then incubated 15 min at 50°C, and subsequently, the suspension was centrifuged (21.000 × g, 20 min, 30°C). The cells were eliminated, and the supernatant was dialyzed extensively against PBS buffer pH 7.4 (for adhesion assays) or 0.1% SDS (for SDS–PAGE analysis) for 24 h at 4°C using Slide-A-Lyer® Dialysis Cassette (ThermoScientific, Rockford, IL, United States). This procedure was applied in three independent cultures.

One-Dimensional SDS–Polyacrylamide Gel Electrophoresis (1-DE) and Western Blotting

Extracts of S-layer proteins in 0.1% SDS were diluted in SDS sample buffer and then heat-denatured 10 min at 95°C. One-dimensional polyacrylamide gel electrophoresis (10.0%) was conducted according to Laemmli (Laemmli, 1970) on a Mini-PROTEAN® Tetra Cell (Bio-Rad, Hercules, CA, United States) and the gels were stained using Coomassie Blue Bio-Safe reagent (Bio-Rad). Alternatively, S-layer protein associated extracts were separated by 10% SDS–PAGE and transferred to PVDF membranes (GE Healthcare). After blocking with 3% non-fat dry milk diluted in TBS (Tris 10 mM, NaCl 0.15 M, 0.3% tween 20), the membranes were incubated overnight at 4°C with primary antibodies purified from rabbit sera (AGRO-BIO, France). These were obtained by injecting the following slpB peptide to rabbits: IDATVDKQNSKGGFGWGG and used at the dilution 1:10,000. After washing, membranes were incubated with secondary antibodies: anti-rabbit IgG conjugated with horseradish peroxidase (1:15,000, AGRO-BIO, France) for 2 h at room temperature. Bound antibodies were visualized with ECL Plus system (GE Healthcare, Vélizy, France) and blots were scanned using the Syngene GBox (Ozyme, Saint-Quentin-en-Yvelines, France). The specificity of anti-SlpB western blotting was checked (Supplementary Figure S1). A single band was observed only in strains expressing SlpB and the labeling pattern was distinct from that of anti-SlpA and anti-SlpE western blotting.

Data Analysis

All the experiments were performed with three technical replicates and three biological replicates, and the results were expressed as means ± standard deviations (SD). Statistical analyses were performed in R Statistical Software (Foundation for Statistical Computing, Vienna, Austria) using ANOVA with Tukey post hoc analyses for multiple comparisons.

Results

Surface Layer Associated Proteins and Adhesion to Cultured Human Colon Cells Are Variable among Strainsof P. freudenreichii

Seven strains of P. freudenreichii from the CIRM-BIA collection (Table 1), CB 118, CB 121, CB 129, CB 134, CB 136, CB 508, and CB 527, have been selected based on preliminary proteomic screening as they all displayed different surface proteomes as shown by their S-layer associated protein pattern after guanidine treatment (Figure 1A). The five proteins, previously identified in CB 129 (SlpA, SlpB, SlpE, InlA, and LspA, see Le Maréchal et al., 2015), and thought to play a role in interactions with the host, are indicated in the figure. Preliminary results pointed out SlpB as a potential key surface protein in P. freudenreichii. We thus developped antibodies in order to confirm this. Western blot analysis using these antibodies further confirmed variability of surface proteins (Figure 1B). SlpB was detected in four strains out of seven, with different intensities. The variability of S-layer associated proteins suggested possible variations regarding interactions with host cells. The seven strains were further compared with respect to adhesion to HT-29 cultured colon cells (Figure 1C). The CB129 strain, exhibited the highest adhesion rate (6.44 CFU/1 HT-29 cell) and was used as the reference (100% adhesion) for comparison with the other strains (100.0% ± 17). Indeed, CB129 showed a significant difference (p < 0.001) with the other P. freudenreichii strains tested under the same experimental conditions. The CB118 strain exhibited a lower but significant adherence percentage of 56.0% ± 10.0 and also displayed SlpB. All the other strains exhibited low adhesion rates without significant differences among them, although CB136 (30.0% ± 5.0), which also displays SlpB, tended to be more adhesive than the rest of this subset. Finally, the lowest adhesion rate was recorded for CB527, 10.0% ± 1.0, for which no surface protein was detected, in accordance with (Deutsch et al., 2017). Different propionibacteria: HT-29-cells ratios were tested for adhesion (100:1, 500:1, and 1,000:1, in technical and biological triplicates) with similar results in adhesion rates ranking. At the MOI of 100:1 used in this study, no internalization of P. freudenreichii was observed (data not shown) using the gentamicin method used by our team to monitor staphylococci internalization (Bouchard et al., 2013).

FIGURE 1.

FIGURE 1

Open in a new tab

Variability of surface proteome and of adhesion among strains of Propionibacterium freudenreichii. (A) Guanidine-extracted surface layer associated proteins are variable. Seven strains of P. freudenreichii were cultured in milk ultrafiltrate and subjected to guanidine-extraction followed by SDS–PAGE (10%) gel electrophoretic analysis of the extracts. Gels were either Coomassie-Blue-stained (A) or transferred to a PVDF membrane. Surface proteins previously identified by mass spectrometry as InlA, LspA, SlpE, SlpA and SlpB in strain CB129 are indicated by 1, 2, 3, 4, and 5, respectively. (B) Western Blotting detection of surface layer protein SlpB. PVDF membranes were treated using rabbit antibodies raised against P. freudenreichii surface layer protein SlpB. (C) Adhesion to cultured human colon epithelial cells is variable. HT-29 cells were cultured to confluence in DMEM prior to co-incubation. Each well (1 × 106 HT-29 cells) was added with 1 × 108 colony-forming unit (CFU) of P. freudenreichii. Co-incubation was 60 min at 37°C in DMEM. After thorough washing with PBS, adhered bacteria were enumerated by CFU plate counting in trypsinized cells. Numbers of the strains used are indicated. Asterisks represent statistically significant differences between strains and were indicated as follows: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Adhesion is presented as a percent of the reference CB129 P. freudenreichii strain. Original gels and western blots, uncropped, are provided in Supplementary Figure S1.

P. freudenreichii CB129 Interacts with Cultured Human Colon Cells

Adhesion of P. freudenreichii to HT-29 cells being demonstrated, we further looked at such an interaction, using three-dimensional confocal microscopy. As seen in Figure 2A, the sections close to the bottom of the slide culture chamber mainly exhibited the blue fluorescence of the HT-29 nuclei, stained with DAPI, a poorly fluorescent cytoplasm, surrounded by a red-stained plasma membrane (lowest images in Figure 2A). Ascending within this “z-stack,” higher sections showed dots with intense red fluorescence, corresponding to cell membranes, indicative of colonocytes microvilli constituting the brush border. Higher sections showed co-localization of these red dots with green-fluorescent propionibacteria, caused by CFSE metabolization within propionibacteria. More precisely, propionibacteria appeared as aggregates, in the intercellular space of the epithelial HT-29 monolayer. This localization of propionibacteria in contact with cells is further illustrated in the reconstituted 3-D view (Figure 2B). Interaction of propionibacteria with cultured human colonocytes was further illustrated by scanning electron microscopy of co-cultures on cell culture inserts (Figure 2C). This revealed localization of propionibacteria at the surface of cells, in contact with the brush border.

FIGURE 2.

FIGURE 2

Open in a new tab

Microscopy imaging of P. freudenreichii Centre International de Ressources Microbiennes–Bactéries d’Intérêt Alimentaire (CIRM-BIA) 129 adhesion to cultured human colon epithelial cells. HT-29 cells were cultured to confluence in DMEM on a slide chamber prior to interaction. P. freudenreichii was cultured in fermented milk ultrafiltrate prior to intracellular labeling of live bacteria using CFSE. Labeled bacteria were then co-incubated with colon cells in a slide chamber prior to washing with PBS and to staining of plasma membrane using Rh-DOPE and mounting in DAPI-containing mounting medium. (A,B) Blue fluorescence evidences colon cells nuclei, red fluorescence their plasma membrane and green fluorescence CFSE-labeled propionibacteria. (A) Z-stack, i.e., confocal images acquired at different “z” altitudes in the labeled preparation. (B) Reconstituted 3-D image showing a cluster of propionibacteria at surface of cells. (C) Scanning electron microscopy observation of propionibacteria adhesion to cultured colon epithelial cells. The same co-incubation was performed in a polycarbonate membrane cell culture insert prior to fixation and scanning electron microscopy observation.

P. freudenreichii CB129 Adhesion to Cultured Human Colon Cells Involves Surface Proteins

To determine whether the presence of surface proteins is involved in the adhesion of P. freudenreichii to HT-29 cells, the method of enzymatic shaving using trypsin was applied, before adhesion assay. A significant reduction (p < 0.001) was observed in the adhesion rate: 21.77 ± 8.10% for shaved bacteria, compared to the positive control consisting of propionibacteria (Figure 3A). Western blot analysis also indicated absence of SlpB at the surface of P. freudenreichii as a result of shaving (Figure 3B). To further confirm the role of surface proteins in adhesion, P. freudenreichii CB129 cells, shaved or not, were incubated with 50 μg of extracted surface proteins. This guanidine extract from the CB129 strain was previously dialyzed against PBS and quantified by Bradford assay. It contained the five proteins (SlpA, SlpB, SlpE, InlA, and LspA, see Figure 1A) in PBS buffer pH 7.4. Adhesion assay was then conducted. This incubation increased the rate of adhesion of P. freudenreichii CB129 to HT-29 cells, from 100.00% ± 8.93 to 317.07% ± 46.68. Furthermore, adhesion rate, which was strongly diminished by enzymatic shaving (33.99% ± 14.30), was restored by this incubation (157.44% ± 18.31, Figure 3C). This further experiment confirmed the key role of at least one of these surface proteins in adhesion.

FIGURE 3.

FIGURE 3

Open in a new tab

Involvement of P. freudenreichii surface proteins in adhesion. (A) Trypsin shaving reduces P. freudenreichii CIRM-BIA 129 adhesion. Human colon cells were cultured in DMEM prior to co-incubation with propionibacteria. Used propionibacteria were either untreated (control) or submitted to trypsin shaving of surface proteins for 60 min (trypsin). Adhered bacteria were enumerated by CFU plate counting in trypsinized cells. (B) Trypsin shaving reduces presence of SlpB protein in P. freudenreichii CIRM-BIA 129 in different times of incubation. P. freudenreichii CIRM-BIA 129 show after different incubations time with trypsin (Tzero min, T30 min, T60 min, and T120 min) a decreased amount of SlpB in Western Blot analysis with anti-SlpB antibodies. (C) Addition of extracted surface layer proteins enhances P. freudenreichii CIRM-BIA 129 adhesion. Human colon cells were cultured prior to co-incubation with propionibacteria. Used propionibacteria were either shaved for 60 min (trypsin) or untreated (control). They were then added with surface layer guanidine extract (50 μg of proteins) or not. Adhesion was quantified by plate CFU counting of propionibacteria after trypsinization of colon cells. Adhesion is presented as a percent of the reference CIRM-BIA 129 P. freudenreichii strain. Asterisks represent statistically significant differences between strains and were indicated as follows: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Adhesion is presented as a percent of the reference CB129 P. freudenreichii strain.

Surface Protein SlpB Plays a Key Role in Adhesion to Cultured Human Colon Cells

In a second approach to inhibit adhesion and to precise the role of specific surface proteins, P. freudenreichii was incubated with antibodies raised against SlpB, at a dilution of 1:10,000, before adhesion assay. This resulted in a significant reduction following incubation with the anti-SlpB antibodies 39.95% ± 6.92 (p < 0.001), (Figure 4A). We then further focused on SlpB and inactivated its gene in P. freudenreichii CB129. The mutant P. freudenreichii CB129ΔslpB was obtained by insertion of the pUC:ΔslpB:CmR suicide plasmid as described in the “Materials and Methods” section (Supplementary Figure S2). The stability of the mutant was validated after growth in the presence or absence of chloramphenicol by checking for the absence of SlpB production. As shown in Figure 4B, one protein band (about 55 kDa in size) was lacking in the mutant S-layer associated proteins guanidine extract (line 2), when compared to the WT parental strain (line 1). Western Blot analysis using antibodies raised against the SlpB protein (Figure 4C) confirmed that this protein was effectively mutated in the mutant (line 2) when compared to the parental strain (line 1). Efficient and specific inactivation of the slpB gene was further established by mass spectrometry analysis of guanidine-extracted S-layer proteins. Indeed, the SlpA, SlpB, and SlpE proteins were clearly identified in the WT CB129 strains, while only SlpA and SlpE were detected in the mutant P. freudenreichii CB129ΔslpB strain (Table 2).

FIGURE 4.

FIGURE 4

Open in a new tab

Key role of surface layer protein SlpB in adhesion. (A) Antibodies reduce P. freudenreichii adhesion and so does slpB gene inactivation. Human colon cells were cultured in DMEM prior to co-incubation with propionibacteria. P. freudenreichii CIRM-BIA 129 was treated with antibodies raised against SlpB prior to adhesion assay. As an alternative, the slpB gene was inactivated in P. freudenreichii CIRM-BIA 129 prior to adhesion assay. Adhesion is presented as a percent of the reference CB129 P. freudenreichii strain. (B) Guanidine-extracted surface layer associated proteins were compared by SDS–PAGE in P. freudenreichii CIRM-BIA 129 wild-type (line 1) and in the corresponding mutant CB129ΔslpB (line 2). (C) The corresponding PVDF membrane was subjected to Western Blotting using rabbit antibodies raised against P. freudenreichii surface layer protein SlpB (B). (D,E) Fluorescently labeled live P. freudenreichii CIRM-BIA 129 adheres to cultured human colon epithelial HT-29 cells. The adhesion of CFSE-labeled propionibacteria was detected by the shift in FL1 intensity (E), compared to HT-29 cells with unlabelled propionibacteria (D). Cells (106) were co-incubated with 108 CFU of CFSE-stained propionibacteria for 1 h. At least 50.000 cells per sample were analyzed. As an alternative, labeled P. freudenreichii mutant CB129ΔslpB was co-incubated with HT-29 cells (F). Original gels and western blots, uncropped, are provided in Supplementary Figure S1. Asterisks represent statistically significant differences between strains and were indicated as follows: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Adhesion is presented as a percent of the reference CB129 P. freudenreichii strain.

Table 2.

Surface-layer proteins identified after Guanidine Hydrochloride extraction.

Wild-type strain
 Delta SlpB strain
Gene name Locus tag Log (e-value)a Cover (%)b Peptidesc Log (e-value)a Cover (%)b Peptidesc
SlpB PFCIRM129_00700 -263.2 74 34 0 0 0
SlpE PFCIRM129_05460 -125.6 50 19 -138.8 55 18
SlpA PFCIRM129_09350 -174.3 75 24 -143.5 68 22
Open in a new tab

aThe e-value is the probability that a given peptide score will be achieved by incorrect matches from a database search. Protein e-value is the product of individual peptide e-value. Protein identifications were automatically validated when they showed at least two unique peptides with an e-value below 0.05 corresponding to log (e-value) < -1.3. bThe percentage of the protein amino acid sequence covered by tandem mass spectrometry identification of peptides. cNumber of unique peptide sequence identified with an individual e-value < 0.01 for this protein.

Adhesion to HT-29 cells was then assessed by CFU counting and the mutant CB129ΔslpB strain was impaired in adhesion (20.66% ± 8.32) when compared to the WT control (100.00% ± 7.37) (Figure 4A, p < 0.001). To confirm this result, adhesion of P. freudenreichii to HT-29 cells, using CFSE-stained propionibacteria, was quantified by flow cytometry. Cells were treated with CFSE-labeled propionibacteria, WT or CB129ΔslpB mutant, for 1 h, before cytometric monitoring of cell fluorescence (Figures 4D–F). A shift in fluorescence intensity (FL1) was observed as a result of fluorescent P. freudenreichii CB129 adhesion to cells (Figure 4E) when compared with control cells without bacteria (Figure 4D). This indicates an increase of fluorescence emission at 488 nm, corresponding to 6-carboxyfluorescein succinimidyl harbored by adhering bacteria, as described previously for lactobacilli (Tiptiri-Kourpeti et al., 2016). By contrast, the mutant CB129ΔslpB strain failed to reproduce this fluorescence shift in HT-29 cells, and the pattern (Figure 4F) was similar to that of HT-29 without bacteria (Figure 4A). Altogether, these results confirm the key role of the SlpB surface protein in adhesion of P. freudenreichii to HT-29 cells.

Discussion

Adhesion is a key determinant of host/bacterium interactions, whether pathogenic or probiotic. Adhesion of probiotic bacteria to host intestinal cells may favor important effects including modulation of mucus secretion (Mack et al., 2003), of defensin production (Schlee et al., 2007, 2008), or the local action of beneficial metabolites. It can improve competitive exclusion of pathogens by adhesion competition (Servin, 2004; Lebeer et al., 2008) and constitutes a key factor for several clinical applications of probiotics in the prevention and treatment of gastrointestinal disorders and of IBD. It may involve, on the bacterial side, various microorganism-associated molecular patterns (MAMPs) including flagellin, fimbriae (also called pili) or other surface proteins including moonlighting proteins and S-layer proteins (Lebeer et al., 2010).

Surface-layer proteins constitute a field of research that deserves further investigation. Although anchored to the cell wall via conserved SLH domains, their extracellular protruding part is highly variable, poorly conserved amongst bacterial species and strains. A previous paradigm described S-layers as a macromolecular paracrystalline network formed by the self-assembly of numerous copies of one monomeric protein or glycoprotein and constituting an extracellular S-layer in many bacteria (Sleytr, 1997; Sára and Sleytr, 2000). This was later challenged by studies on Lactobacillus acidophilus showing that a S-layer can contain various S-layer proteins or SLPs (Hymes et al., 2016). These proteins are in fact versatile molecules that may play an important role in growth and survival, maintenance of cell integrity, enzyme display, molecular sieving, co-aggregation, immunomodulation, as well as adhesion and persistence within the animal host (Lebeer et al., 2010; Fagan and Fairweather, 2014). In P. freudenreichii, such proteins were shown to be involved in immunomodulatory interactions with the host (Le Maréchal et al., 2015), a property highly strain-dependent (Mitsuyama et al., 2007; Foligné et al., 2010, 2013). Indeed, a functional role in immunomodulation by P. freudenreichii was recently attributed to a set of proteins: SlpB, SlpE, two putative S-layer proteins with SLH domains, and HsdM3, predicted as cytoplasmic (Deutsch et al., 2017).

Variability of P. freudenreichii surface proteins may thus be related to variability in functional properties. In this context, we have selected in the present work seven P. freudenreichii strains with different patterns evidenced in a preliminary study.

We confirm here that P. freudenreichii S-layer proteins are variable, and so is its ability to adhere to cultured human epithelial cells, as determined by quantitative culturing (Mack et al., 1999), which suggests a functional link between variations in the surface protein pattern. P. freudenreichii CIRM-BIA 129, shown to alleviate symptoms of acute colitis in mice, displays S-layer associated proteins and the highest adhesion ability, whatever the bacteria/cell ratio (100:1; 500:1; and 1,000:1). Moreover, at a ratio of 100/1, no internalization was observed. This suggests that propionibacteria either do not internalize into cultured HT-29 cells, or do not suvive within the cells. Cultured colon epithelial HT-29 cells do not produce mucus in our conditions. This suggests that P. freudenreichii interacts with epithelial cell surface compounds rather than mucins, a property previously reported for the probiotic L. acidophilus (Johnson et al., 2013). Interestingly, CB129 was shown to restore expression of ZO-1, a key protein of tight junctions which expression was impaired in colitis (Plé et al., 2015), as part of its anti-inflammatory effect. Adhesion close to these junctions may favor the local action of propionibacteria via local release of propionate, the major metabolite of propionibacteria, which was shown to improve intestinal barrier function and to restore expression of ZO-1 in DSS-treated mice (Tong et al., 2016). Accordingly, protection toward inflammation-induced barrier defects was reported for the probiotic product VSL#3 (Krishnan et al., 2016).

Enzymatic shaving of surface proteins reduced adhesion and was previously shown to hydrolyze at least 16 distinct proteins (Le Maréchal et al., 2015). Dramatic inhibition of adhesion was observed following blockage with antibodies raised against SlpB. Interruption of the slpB gene in CB129 strain also resulted in a drastic reduction (P < 0.01) in adhesion. Moreover, addition of purified S-layer proteins restored the adhesion that was suppressed in P. freudenreichii by enzymatic shaving. Altogether, these results indicate a role of P. freudenreichii S-layer protein, including SlpB, in adhesion, as was reported for the SlpA protein in L. acidophilus NCFM (Buck et al., 2005).

This study evidenced a key role of one of the P. freudenreichii S-layer proteins in adhesion to human intestinal cells. Understanding determinants of probiotic action is a key challenge. It opens new avenues for the screening of most promising propionibacteria strains, by monitoring their expression, and for the development of new functional products containing them. It is particularly relevant in the context of pathogens competitive exclusion and inflammation remediation.

Author Contributions

GJ and FdC designed the research. GJ, YL, and VA supervised the work. FdC, HR, SH, FG, MD, SD, and JJ took part to the experiments. FdC and GJ wrote the manuscript. YL and VA corrected the manuscript.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

The authors thank Sandrine Parayre for expert technical assistance and Clément Thal for useful discussions and advices.

Funding. This work was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil). HR is the recipient of a doctoral fellowship from Bba, FG from Biodis.

Supplementary Material

The Supplementary Material for this article can be found online at: http://journal.frontiersin.org/article/10.3389/fmicb.2017.01033/full#supplementary-material

FIGURE S1

Specificity of the anti-SlpB antibodies. The whole gels (I, II) and whole blots (II, IV) corresponding to Figures 1, 4 are shown. A single band reacting with anti-SlpB antibodies is evidenced. Moreover, specific inactivation of slpB gene leads to disappearance of this reactive band (IV). Finally, western blot using anti-SlpB antibodies reveals the SlpB protein only in strains which harbor the corresponding slpB gene, as indicated by the Table (V). In supplemental western blots of the same extracts (VI), sera directed against SlpA and SlpE evidence a distinct pattern. In particular, the two close Coomassie-stained bands, 58 and 56 kDa, were identified by western blot (this work) and by mass spectrometry (Le Maréchal et al., 2015) as SlpA and slpB, respectively.

Click here for additional data file. (96.3KB, jpg)
Click here for additional data file. (96.3KB, jpg)
FIGURE S2

Interruption of slpB gene using suicide vector pUC:ΔslpB:CmR. (A–C) Schematic view of homologous recombination producing a mutant CB 128ΔslpB. Disruption of slpB gene in CB 129 WT by suicide vector pUC:CmR harboring 520-bp of slpB. Mutant strain show a chloramphenicol resistance by insertion of cassette containing CmR. (D) Targeting sequence used to inactivate. Partial sequence of slpB gene in CB 129 WT and sequence used to homologous recombination (red). The primers annealing site are indicated as underlined bases and oligonucleotides sequence are shown in figure.

Click here for additional data file. (139KB, jpg)
Click here for additional data file. (139KB, jpg)

References

  1. Belkaid Y., Hand T. (2014). Role of the microbiota in immunity and inflammation. Cell 157 121–141. 10.1016/j.cell.2014.03.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bensi G., Mora M., Tuscano G., Biagini M., Chiarot E., Bombaci M., et al. (2012). Multi high-throughput approach for highly selective identification of vaccine candidates: the group a Streptococcus case. Mol. Cell. Proteomics 11 M111.015693 10.1074/mcp.M111.015693 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berlec A., Zadravec P., Jevnikar Z., Štrukelj B. (2011). Identification of candidate carrier proteins for surface display on Lactococcus lactis by theoretical and experimental analyses of the surface proteome. Appl. Environ. Microbiol. 77 1292–1300. 10.1128/AEM.02102-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bøhle L. A., Riaz T., Egge-Jacobsen W., Skaugen M., Busk ØL., Eijsink V. G., et al. (2011). Identification of surface proteins in Enterococcus faecalis V583. BMC Genomics 12:135 10.1186/1471-2164-12-135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bouchard D. S., Rault L., Berkova N., Le Loir Y., Even S. (2013). Inhibition of Staphylococcus aureus invasion into bovine mammary epithelial cells by contact with live Lactobacillus casei. Appl. Environ. Microbiol. 79 877–885. 10.1128/AEM.03323-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bouglé D., Roland N., Lebeurrier F., Arhan P. (1999). Effect of propionibacteria supplementation on fecal bifidobacteria and segmental colonic transit time in healthy human subjects. Scand. J. Gastroenterol. 34 144–148. [DOI] [PubMed] [Google Scholar]
  7. Bryson K., Loux V., Bossy R., Nicolas P., Chaillou S., van de Guchte M., et al. (2006). AGMIAL: implementing an annotation strategy for prokaryote genomes as a distributed system. Nucleic Acids Res. 34 3533–3545. 10.1093/nar/gkl471 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Buck B. L., Altermann E., Svingerud T., Klaenhammer T. R. (2005). Functional analysis of putative adhesion factors in Lactobacillus acidophilus NCFM. Appl. Environ. Microbiol. 71 8344–8351. 10.1128/AEM.71.12.8344-8351.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. ClinicalTrials.gov (2017). Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis. Available at: https://clinicaltrials.gov/ct2/show/NCT02488954 [accessed October 11, 2016]. [Google Scholar]
  10. Cousin F. J., Foligné B., Deutsch S.-M., Massart S., Parayre S., Le Loir Y., et al. (2012a). Assessment of the probiotic potential of a dairy product fermented by Propionibacterium freudenreichii in piglets. J. Agric. Food Chem. 60 7917–7927. 10.1021/jf302245m [DOI] [PubMed] [Google Scholar]
  11. Cousin F. J., Jouan-Lanhouet S., Dimanche-Boitrel M.-T., Corcos L., Jan G. (2012b). Milk fermented by Propionibacterium freudenreichii induces apoptosis of HGT-1 human gastric cancer cells. PLoS ONE 7:e31892 10.1371/journal.pone.0031892 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cousin F. J., Mater D. D. G., Foligne B., Jan G. (2010). Dairy propionibacteria as human probiotics: a review of recent evidence. Dairy Sci. Technol. 91 1–26. 10.1051/dst/2010032 [DOI] [Google Scholar]
  13. de Souza H. S. P., Fiocchi C. (2016). Immunopathogenesis of IBD: current state of the art. Nat. Rev. Gastroenterol. Hepatol. 13 13–27. 10.1038/nrgastro.2015.186 [DOI] [PubMed] [Google Scholar]
  14. Deutsch S. M., Mariadassou M., Nicolas P., Parayre S., Le Guellec R., Chuat V., et al. (2017). Identification of proteins involved in the anti-inflammatory properties of Propionibacterium freudenreichii by means of a multi-strain study. Sci. Rep 7:46409 10.1038/srep46409 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Deutsch S.-M., Parayre S., Bouchoux A., Guyomarc’h F., Dewulf J., Dols-Lafargue M., et al. (2012). Contribution of surface β-glucan polysaccharide to physicochemical and immunomodulatory properties of Propionibacterium freudenreichii. Appl. Environ. Microbiol. 78 1765–1775. 10.1128/AEM.07027-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fagan R. P., Fairweather N. F. (2014). Biogenesis and functions of bacterial S-layers. Nat. Rev. Microbiol. 12 211–222. 10.1038/nrmicro3213 [DOI] [PubMed] [Google Scholar]
  17. Foligné B., Breton J., Mater D., Jan G. (2013). Tracking the microbiome functionality: focus on Propionibacterium species. Gut 62 1227–1228. 10.1136/gutjnl-2012-304393 [DOI] [PubMed] [Google Scholar]
  18. Foligné B., Deutsch S.-M., Breton J., Cousin F. J., Dewulf J., Samson M., et al. (2010). Promising immunomodulatory effects of selected strains of dairy propionibacteria as evidenced in vitro and in vivo. Appl. Environ. Microbiol. 76 8259–8264. 10.1128/AEM.01976-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Food and Agriculture Organization of the United Nations and World Health Organization (eds) (2002). Probiotics in Food: Health and Nutritional Properties and Guidelines for Evaluation. Rome: Food and Agriculture Organization. [Google Scholar]
  20. Havenaar R., Brink B. T., Huisin’t Veld J. H. J. (1992). “Selection of strains for probiotic use,” in Probiotics eds Fuller R. (Dordrecht: Springer; ) 209–224. [Google Scholar]
  21. Hojo K., Yoda N., Tsuchita H., Ohtsu T., Seki K., Taketomo N., et al. (2002). Effect of ingested culture of Propionibacterium freudenreichii ET-3 on fecal microflora and stool frequency in healthy females. Biosci. Microflora 21 115–120. 10.12938/bifidus1996.21.115 [DOI] [Google Scholar]
  22. Huang Y., Adams M. C. (2003). An in vitro model for investigating intestinal adhesion of potential dairy propionibacteria probiotic strains using cell line C2BBe1. Lett. Appl. Microbiol. 36 213–216. [DOI] [PubMed] [Google Scholar]
  23. Hymes J. P., Johnson B. R., Barrangou R., Klaenhammer T. R. (2016). Functional analysis of an S-Layer-Associated fibronectin-binding protein in Lactobacillus acidophilus NCFM. Appl. Environ. Microbiol. 82 2676–2685. 10.1128/AEM.00024-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jan G., Belzacq A.-S., Haouzi D., Rouault A., Métivier D., Kroemer G., et al. (2002). Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death. Differ. 9 179–188. 10.1038/sj.cdd.4400935 [DOI] [PubMed] [Google Scholar]
  25. Johnson B., Selle K., O’Flaherty S., Goh Y. J., Klaenhammer T. (2013). Identification of extracellular surface-layer associated proteins in Lactobacillus acidophilus NCFM. Microbiol. Read. Engl. 159 2269–2282. 10.1099/mic.0.070755-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kaneko T. (1999). A novel bifidogenic growth stimulator produced by Propionibacterium freudenreichii. Biosci. Microflora 18 73–80. 10.12938/bifidus1996.18.73 [DOI] [PubMed] [Google Scholar]
  27. Krishnan M., Penrose H. M., Shah N. N., Marchelletta R. R., McCole D. F. (2016). VSL#3 probiotic stimulates T-cell Protein tyrosine phosphatase-mediated recovery of IFN-γ-induced intestinal epithelial barrier defects. Inflamm. Bowel Dis. 22 2811–2823. 10.1097/MIB.0000000000000954 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Laemmli U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 680–685. 10.1038/227680a0 [DOI] [PubMed] [Google Scholar]
  29. Lan A., Lagadic-Gossmann D., Lemaire C., Brenner C., Jan G. (2007). Acidic extracellular pH shifts colorectal cancer cell death from apoptosis to necrosis upon exposure to propionate and acetate, major end-products of the human probiotic propionibacteria. Apoptosis Int. J. Program. Cell Death 12 573–591. 10.1007/s10495-006-0010-3 [DOI] [PubMed] [Google Scholar]
  30. Le Maréchal C., Peton V., Plé C., Vroland C., Jardin J., Briard-Bion V., et al. (2015). Surface proteins of Propionibacterium freudenreichii are involved in its anti-inflammatory properties. J. Proteomics 113 447–461. 10.1016/j.jprot.2014.07.018 [DOI] [PubMed] [Google Scholar]
  31. Lebeer S., Vanderleyden J., De Keersmaecker S. C. J. (2008). Genes and molecules of lactobacilli supporting probiotic action. Microbiol. Mol. Biol. Rev. 72 728–764. 10.1128/MMBR.00017-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lebeer S., Vanderleyden J., De Keersmaecker S. C. J. (2010). Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat. Rev. Microbiol. 8 171–184. 10.1038/nrmicro2297 [DOI] [PubMed] [Google Scholar]
  33. Lortal S., Rouault A., Cesselin B., Sleytr U. B. (1993). Paracrystalline surface layers of dairy propionibacteria. Appl. Environ. Microbiol. 59 2369–2374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mack D. R., Ahrne S., Hyde L., Wei S., Hollingsworth M. A. (2003). Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52 827–833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mack D. R., Michail S., Wei S., McDougall L., Hollingsworth M. A. (1999). Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276 G941–G950. [DOI] [PubMed] [Google Scholar]
  36. Malik A. C., Reinbold G. W., Vedamuthu E. R. (1968). An evaluation of the taxonomy of Propionibacterium. Can. J. Microbiol. 14 1185–1191. [DOI] [PubMed] [Google Scholar]
  37. Mayrhofer C., Krieger S., Allmaier G., Kerjaschki D. (2006). DIGE compatible labelling of surface proteins on vital cells in vitro and in vivo. Proteomics 6 579–585. 10.1002/pmic.200500104 [DOI] [PubMed] [Google Scholar]
  38. Michaux C., Saavedra L. F. R., Reffuveille F., Bernay B., Goux D., Hartke A., et al. (2013). Cold-shock RNA-binding protein CspR is also exposed to the surface of Enterococcus faecalis. Microbiol. Read. Engl. 159 2153–2161. 10.1099/mic.0.071076-0 [DOI] [PubMed] [Google Scholar]
  39. Mitsuyama K., Masuda J., Yamasaki H., Kuwaki K., Kitazaki S., Koga H., et al. (2007). Treatment of ulcerative colitis with milk whey culture with Propionibacterium freudenreichii. J. Intest. Microbiol. 21 143–147. 10.11209/jim.21.143 [DOI] [Google Scholar]
  40. Moussavi M., Adams M. C. (2010). An in vitro study on bacterial growth interactions and intestinal epithelial cell adhesion characteristics of probiotic combinations. Curr. Microbiol. 60 327–335. 10.1007/s00284-009-9545-1 [DOI] [PubMed] [Google Scholar]
  41. Ouwehand A. C., Lagström H., Suomalainen T., Salminen S. (2002). Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann. Nutr. Metab. 46 159–162. [DOI] [PubMed] [Google Scholar]
  42. Ouwehand A. C., Tölkkö S., Kulmala J., Salminen S., Salminen E. (2000). Adhesion of inactivated probiotic strains to intestinal mucus. Lett. Appl. Microbiol. 31 82–86. [DOI] [PubMed] [Google Scholar]
  43. Plé C., Breton J., Richoux R., Nurdin M., Deutsch S.-M., Falentin H., et al. (2016). Combining selected immunomodulatory Propionibacterium freudenreichii and Lactobacillus delbrueckii strains: reverse engineering development of an anti-inflammatory cheese. Mol. Nutr. Food Res. 60 935–948. 10.1002/mnfr.201500580 [DOI] [PubMed] [Google Scholar]
  44. Plé C., Richoux R., Jardin J., Nurdin M., Briard-Bion V., Parayre S., et al. (2015). Single-strain starter experimental cheese reveals anti-inflammatory effect of Propionibacterium freudenreichii CIRM BIA 129 in TNBS-colitis model. J. Funct. Foods 18(Part A) 575–585. 10.1016/j.jff.2015.08.015 [DOI] [Google Scholar]
  45. Preising J., Philippe D., Gleinser M., Wei H., Blum S., Eikmanns B. J., et al. (2010). Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis. Appl. Environ. Microbiol. 76 3048–3051. 10.1128/AEM.03127-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Richoux R., Faivre É., Kerjean J.-R. (1998). Effet de la teneur en NaCl sur la fermentation du lactate par Propionibacterium freudenreichii dans des minifromages à pâte cuite. Le Lait 78 319–331. 10.1051/lait:1998332 [DOI] [Google Scholar]
  47. Riedel C. U., Foata F., Goldstein D. R., Blum S., Eikmanns B. J. (2006). Interaction of bifidobacteria with Caco-2 cells-adhesion and impact on expression profiles. Int. J. Food Microbiol. 110 62–68. 10.1016/j.ijfoodmicro.2006.01.040 [DOI] [PubMed] [Google Scholar]
  48. Rodríguez-Ortega M. J., Norais N., Bensi G., Liberatori S., Capo S., Mora M., et al. (2006). Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat. Biotechnol. 24 191–197. 10.1038/nbt1179 [DOI] [PubMed] [Google Scholar]
  49. Sára M., Sleytr U. B. (2000). S-Layer proteins. J. Bacteriol. 182 859–868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Schlee M., Harder J., Köten B., Stange E. F., Wehkamp J., Fellermann K. (2008). Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin. Exp. Immunol. 151 528–535. 10.1111/j.1365-2249.2007.03587.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Schlee M., Wehkamp J., Altenhoefer A., Oelschlaeger T. A., Stange E. F., Fellermann K. (2007). Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect. Immun. 75 2399–2407. 10.1128/IAI.01563-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Seki K., Nakao H., Umino H., Isshiki H., Yoda N., Tachihara R., et al. (2004). Effects of fermented milk whey containing novel bifidogenic growth stimulator produced by propionibacterium on fecal bacteria, putrefactive metabolite, defecation frequency and fecal properties in senile volunteers needed serious nursing-care taking enteral nutrition by tube Feeding. J. Intest. Microbiol. 18 107–115. 10.11209/jim.18.107 [DOI] [Google Scholar]
  53. Servin A. L. (2004). Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol. Rev. 28 405–440. 10.1016/j.femsre.2004.01.003 [DOI] [PubMed] [Google Scholar]
  54. Sleytr U. B. (1997). I. Basic and applied S-layer research: an overview. FEMS Microbiol. Rev. 20 5–12. 10.1111/j.1574-6976.1997.tb00301.x [DOI] [Google Scholar]
  55. Thiel A., Eikmanns B., Salminen S., Ouwehand A. C. (2004). In vitro adhesion of propionibacteria to human intestinal mucus [dairy products]. Ital. J. Food Sci. Available at: http://agris.fao.org/agris-search/search.do?recordID=IT2005600093 [Accessed October 11, 2016]. [Google Scholar]
  56. Thierry A., Richoux R., Kerjean J.-R. (2004). Isovaleric acid is mainly produced by Propionibacterium freudenreichii in Swiss cheese. Int. Dairy J. 14 801–807. 10.1016/j.idairyj.2004.02.002 [DOI] [Google Scholar]
  57. Tiptiri-Kourpeti A., Spyridopoulou K., Santarmaki V., Aindelis G., Tompoulidou E., Lamprianidou E. E., et al. (2016). Lactobacillus casei exerts anti-proliferative effects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells. PLoS ONE 11:e0147960 10.1371/journal.pone.0147960 [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Tong L.-C., Wang Y., Wang Z.-B., Liu W.-Y., Sun S., Li L., et al. (2016). Propionate ameliorates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress. Front. Pharmacol. 7:253 10.3389/fphar.2016.00253 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Tuomola E. M., Ouwehand A. C., Salminen S. J. (1999). Human ileostomy glycoproteins as a model for small intestinal mucus to investigate adhesion of probiotics. Lett. Appl. Microbiol. 28 159–163. [DOI] [PubMed] [Google Scholar]
  60. van de Guchte M., Chaze T., Jan G., Mistou M.-Y. (2012). Properties of probiotic bacteria explored by proteomic approaches. Curr. Opin. Microbiol. 15 381–389. 10.1016/j.mib.2012.04.003 [DOI] [PubMed] [Google Scholar]
  61. Vitetta L., Briskey D., Alford H., Hall S., Coulson S. (2014). Probiotics, prebiotics and the gastrointestinal tract in health and disease. Inflammopharmacology 22 135–154. 10.1007/s10787-014-0201-4 [DOI] [PubMed] [Google Scholar]
  62. Vitetta L., Hall S., Coulson S. (2015). Metabolic interactions in the gastrointestinal tract (GIT): host, commensal, probiotics, and bacteriophage influences. Microorganisms 3 913–932. 10.3390/microorganisms3040913 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Ythier M., Resch G., Waridel P., Panchaud A., Gfeller A., Majcherczyk P., et al. (2012). Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypes. Mol. Cell. Proteomics MCP 11 1123–1139. 10.1074/mcp.M111.014191 [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Zarate G. (2012). “Dairy propionibacteria: less conventional probiotics to improve the human and animal Health,” in Probiotic in Animals ed. Rigobelo E. (Rejika: InTech; ). [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

FIGURE S1

Specificity of the anti-SlpB antibodies. The whole gels (I, II) and whole blots (II, IV) corresponding to Figures 1, 4 are shown. A single band reacting with anti-SlpB antibodies is evidenced. Moreover, specific inactivation of slpB gene leads to disappearance of this reactive band (IV). Finally, western blot using anti-SlpB antibodies reveals the SlpB protein only in strains which harbor the corresponding slpB gene, as indicated by the Table (V). In supplemental western blots of the same extracts (VI), sera directed against SlpA and SlpE evidence a distinct pattern. In particular, the two close Coomassie-stained bands, 58 and 56 kDa, were identified by western blot (this work) and by mass spectrometry (Le Maréchal et al., 2015) as SlpA and slpB, respectively.

Click here for additional data file. (96.3KB, jpg)
Click here for additional data file. (96.3KB, jpg)
FIGURE S2

Interruption of slpB gene using suicide vector pUC:ΔslpB:CmR. (A–C) Schematic view of homologous recombination producing a mutant CB 128ΔslpB. Disruption of slpB gene in CB 129 WT by suicide vector pUC:CmR harboring 520-bp of slpB. Mutant strain show a chloramphenicol resistance by insertion of cassette containing CmR. (D) Targeting sequence used to inactivate. Partial sequence of slpB gene in CB 129 WT and sequence used to homologous recombination (red). The primers annealing site are indicated as underlined bases and oligonucleotides sequence are shown in figure.

Click here for additional data file. (139KB, jpg)
Click here for additional data file. (139KB, jpg)

Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES